Define the proposed scope
A defined medication-use safety system, care setting, service line or organizational operating unit approved in scope.
MSS Preparation Center
Prepare for Medication Safety Systems Accreditation
A step-by-step, non-scored preparation path that shows applicants what to organize, what reviewers will trace and how scope is defined.
Preparation sequence
Seven steps from scope definition to an audit-ready evidence file
Read the standard stack
Use CHSPS-CORE-100 + CHSPS-MSS-310. Mark every requirement as applicable, not applicable with rationale, or needing evidence.
Build the controlled evidence index
Link each applicable requirement to the authoritative policy, record, report, system output or sample that demonstrates implementation.
Test implementation with tracers
Trace real operations such as high-risk medication safeguard and medication reconciliation case.
Close material gaps
Correct the immediate condition, identify cause, assign corrective action and verify effectiveness when risk or recurrence warrants it.
Complete internal management review
Confirm scope, unresolved risk, evidence integrity, staffing, vendors, changes and readiness for independent review.
Submit the eligibility and scope inquiry
CHSPS confirms fit and scope before formal application and secure evidence submission.
No predictive pass score. CHSPS accreditation decisions are requirement- and evidence-based. A single unresolved high-risk control failure can matter more than many complete low-risk records.
CHSPS-MSS-310
Organize evidence around the published standard
The cards below summarize the controlled standard structure. The PDF and machine record remain authoritative.
Safety governance
Show the medication-safety governance structure, accountable leaders, committee or review mechanisms, escalation authority, risk priorities, action tracking and evidence that safety decisions are implemented across the defined scope.
Risk assessment
Show how medication-use risks are identified and prioritized, data and event sources considered, responsible reviewers, risk-control decisions, reassessment triggers and completed mitigation actions.
Transitions
Show medication reconciliation and transition-of-care controls, responsible roles, source reconciliation, discrepancy resolution, communication at transfer or discharge and representative completed cases.
High-alert medications
Show the defined high-alert medication list or equivalent risk classification, safeguards, independent or technological checks where used, storage and administration controls, exceptions and monitoring of safeguard performance.
Prescribing & CDS
Show prescribing controls and clinical decision support governance, alert or rule design, approval, testing, override monitoring, change control and representative evidence that intended safeguards are active.
Verification
Show pharmacist or other required verification workflows, role authorization, required checks, exception handling, queue or turnaround monitoring and representative records linking the verification to the medication order.
Preparation & storage
Show preparation, labeling, storage, segregation, environmental or stability controls as applicable, inspections, discrepancy handling and representative records demonstrating controlled medication handling.
Administration
Show patient, medication, dose, route and timing controls as applicable to scope, barcode or other technology use, independent checks where required, exception workflows and representative administration records.
Monitoring
Show patient and therapy monitoring requirements, trigger thresholds, responsible roles, escalation, follow-up, documentation and representative cases where monitoring changed or confirmed medication management.
Learning system
Show event and near-miss reporting, triage, investigation, causal analysis, action assignment, communication, effectiveness review and trend analysis demonstrating that reported safety signals lead to learning.
Technology
Show governance of medication technologies, configuration ownership, testing, access control, downtime procedures, interface or data-quality monitoring, change management and review of technology-related events.
Supply resilience
Show shortage, recall and supply-disruption controls, risk assessment, therapeutic or operational alternatives, communication, inventory actions, approval and monitoring of temporary safeguards.
Diversion interface
Show how medication-safety processes interface with diversion prevention and response, including discrepancy escalation, access review, investigation coordination, patient-safety assessment and documented follow-up.
Workforce competence
Show role-specific medication-safety competencies, initial and continuing assessment, high-risk skill controls, overdue or failed competency response and evidence that authorized staff remain current.
Patient partnership
Show how patients or caregivers receive and contribute medication information, how discrepancies and concerns are captured, accessibility or language needs are addressed and safety feedback is incorporated.
Performance
Show medication-safety measures, event and near-miss trends, denominator and data-source controls where applicable, management review, improvement priorities and evidence that interventions are evaluated for effectiveness.
Implementation review
Expect reviewers to trace real operations, not only policies.
| Representative tracer | What to be ready to show |
|---|---|
| high-risk medication safeguard | Trace one high-risk medication from order or request through verification, preparation or dispensing, administration and monitoring, showing each required safeguard, any override and the retained evidence. |
| medication reconciliation case | Trace one transition case through medication-history collection, source comparison, discrepancy identification, clarification, reconciliation, communication and final documented medication list. |
| safety event to CAPA | Trace one medication-safety event or near miss from report through triage, investigation, causal analysis, immediate risk control, corrective or preventive action, effectiveness review and closure. |
| recall or urgent safety communication | Trace one recall, shortage or urgent safety notice from receipt through impact assessment, inventory or therapy action, communication, patient or prescriber follow-up where applicable and documented closure. |
Applicant tools
Use your own system or start with these structured templates.
Applicant Preparation Guide
Program-specific scope, evidence, tracer and pre-submission guidance.
Download PDFScope Worksheet
Define included entities, programs or systems, sites, delivery environments and exclusions.
Download CSVEvidence Index
Map each applicable requirement to authoritative evidence, owner and status.
Download CSVSelf-Assessment Workbook
Use the CHSPS general workbook alongside the program-specific evidence index.
Download DOCXPost-award planning
Review annual reporting, material-change notification and renewal responsibilities so ongoing controls are designed before application.
View maintenance requirementsReady for scope confirmation?
Start MSS InquiryStart with the free MSS eligibility inquiry.
Continuous intake - eligibility and scope review first. Formal application is available after written eligibility and scope confirmation.